Influence of depression and HIV serostatus on the neuropsychological performance of injecting drug users

Psychiatry and Clinical Neurosciences

Volumn 59, Issue 4, 2005, Pages 372-378

  Waldrop Valverde, Drenna ^a   Ownby, Raymond L ^a   Kumar, Mahendra ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Acquired immunodeficiency syndrome; Brain; Psychiatry; Psychology

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; COGNITION; CONTROLLED STUDY; DEPRESSION; DISEASE MARKER; DISEASE SEVERITY; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST;

ADOLESCENT; ADULT; COGNITION; DEPRESSIVE DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); ETHNIC GROUPS; FACTOR ANALYSIS, STATISTICAL; FEMALE; FLORIDA; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SEX CHARACTERISTICS; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL LOAD;

EID: 23744510502     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2005.01388.x     Document Type: Article

References (39)

1. Grant I, Hampton Atkinson J, Hesselink JR et al. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Ann. Intern. Med. 1987; 107: 828-836.
2. Martin EM, Robertson LC, Edelstein HE et al. Performance of patients with early HIV-1 infection on the Stroop task. J. Clin. Exp. Neuropsychol. 1992; 14: 857-868.
3. Peavy G, Jacobs D, Salmon DP et al. Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. J. Clin. Exp. Neuropsychol. 1994; 16: 508-523.
4. Wilkie FL, Goodkin K, van Zuilen MH, Tyll MD, Lecusay R, Edwin T. Cognitive effects of HIV-1 infection. CNS Spectr. 2000; 5: 33-51.
5. Centers for Disease Control. Division of HIV/AIDS Prevention: Fact Sheets [on-Line]. 2003. http://www.cdc.gov/ hiv/pubs/facts.htm.
6. Concha M, Selnes OA, McArthur JC et al. Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users. Int. J. Addict. 1995; 30: 823-841.
7. Ahmad S, Ahmad H, Bindra G. Cognitive impairment in chronic heroin addicts. J. Pers. Clin. Stud. 1989; 5: 237-240.
8. Ardila A, Rosselli M, Strumwasser S. Neuropsychological effects of cocaine abuse. Int. J. Neurosci. 1991; 57: 73-79.
9. Berry J, van Gorp WG, Herzberg DS et al. Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. Drug Alcohol Depend. 1993; 32: 231-237.
10. Meek PS, Clark HW, Solana VL. Neurocognitive impairment: the unrecognized component of dual diagnoses in substance abuse treatment. J. Psychoactive Drugs 1989; 21: 153-160.
11. Mittenberg W, Motta S. Effects of chronic cocaine abuse on memory and learning. Arch. Clin. Neuropsychol. 1993; 8: 447-461.
12. Ranseen JD, Hays LR, Dickson LR, Gilmore R. Neuropsychological impairment of chronic cocaine abusers. Am. J. Drug Alcohol Abuse 1990; 18: 131-144.
13. Strickland TL, Miller BL, Kowell A, Stein R. Neurobiology of cocaine-induced organic brain impairment: contribution from functional neuroimaging. Neuropsychol. Rev. 1993; 8: 1-9.
14. Cohen RM, Weingartner H, Smallberg SA, Pickar D, Murphy S. Effort and cognition in depression. Arch. Gen. Psychiatry 1982; 39: 593-597.
15. Weingartner H, Gold P, Ballenger JD et al. Effects of vasopressin on human memory functions. Science 1981; 211: 601-603.
16. Raskin A, Freidman AS, DeMascio A. Cognitive and performance deficits in depression. Psychopharmacol. Bull. 1982; 18: 96-202.
17. Dinwiddie SH, Reich T, Cloninger RC. Psychiatric comborbidity and suicidality among intravenous drug users. J. Clin. Psychiatry 1992; 53: 364-369.
18. Rounsaville BJ, Weissman MM, Kleber H, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch. Gen. Psychiatry 1982; 39: 161-166.
19. Lipsitz JD, Williams J, Rabkin JG et al. Psychopathology in male and female intravenous drug users with and without HIV infection. Am. J. Psychiatry 1994; 151: 1662-1668.
20. Starace F, Ammasari A, Trotta MP et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2002; 31: S136-S139.
21. Heaton RK, Marcotte TD, Mindt MR et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J. Int. Neuropsychol. Soc. 2004; 10: 317-331.
22. Hinkin CH, Castellon SA, Durvasula RS et al. Medication adherence among HIV+ adults. Neurology 2002; 59: 1944-1950.
23. Waldrop-Valverde D, Ownby RL, Wilkie FL, Mack A, Kumar M, Metsch L. Neurocognitive aspects of medication adherence in HIV positive injecting drug users. AIDS Behav. 2005 (in press).
24. Vazquez-Justo E, Alvarez MR, Ferraces Otero MJ. Influence of depressed mood on neuropsychologic performance in HIV-seropositive drug users. Psychiatry Clin. Neurosci. 2003; 57: 251-258.
25. Waldrop D, Kumar M. RAVLT performance and HIV infection in injecting drug users. Poster presented at the annual meeting of the National Academy of Neuropsychology, San Francisco, 2001.
26. Wilkie FL, Eisdorfer C, Morgan R, Loewenstein DA, Szapocznik J. Cognition in early human immunodeficiency virus infection. Arch. Neurol. 1990; 47: 433-440.
27. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961; 4: 53-63.
28. Lezak M. (ed.). Neuropsychological Assessment, 3rd edn. Oxford University Press, New York, 1995.
29. Rey A. L'examen Clinique En Psychologie. Presses Universitaires de France, Paris, 1964.
30. Corwin J, Bylsma FW. 'Psychological examination of traumatic encephalopathy' by A. Rey and 'The Complex Figure Test' by P.A. Osterrieth. Clin. Neuropsychol. 1993; 7: 3-21.
31. D'Elia L, Satz P. Color Trails 1 and 2. Psychological Assessment Resources, Odessa, FL, 1989.
32. Klove H. Clinical neuropsychology. Med. Clin. North Am. 1963; 47: 1647-1658.
33. Wechsler D. Wechsler Adult Intelligence Scale, 3rd edn, Manual. Psychological Corporation, New York, 1997.
34. Spreen O, Strauss E. A Compendium of Neuropsychological Tests. Oxford University Press, New York, 1991.
35. Cassons G, Wolfe L, Zola M. The neuropsychology of depressions. J. Neuropsychiatry 1990; 2: 202-213.
36. Bornstein RA, Pace P, Rosenberber P et al. Depression and neuropsychological performance in asymptomatic HIV infection. Am. J. Psychiatry 1993; 150: 922-127.
37. Grant I, Olsen RA, Hampton Atkinson OJ et al. Depressed mood does not explain neuropsychological deficits in HIV-infected persons. Neuropsychology 1993; 7: 53-61.
38. Hinkin CH, van Gorp WG, Satz P, Weisman JD, Thommes J, Buckingham S. Depressed mood and its relationship to neuropsychological test performance in HIV-1 seropositive individuals. J. Clin. Exp. Neuropsychol. 1992; 14: 289-297.
39. Stein MD, Solomon DA, Herman D, Anderson BJ, Miller I. Depression severity and drug injection HIV risk behaviors. Am. J. Psychiatry 2003; 160: 1659-1662.